HLA-C and viral infectious disease: From the findings of the current study, two mechanisms employed by the hosts when challenged by SARS-CoV-2 are possible, one involving an HLA-C ligand (e.g., HLA-C*04:01) interacting with Natural Killer (NK) cells as observed for several viral infections, and a second being cytotoxic CD8+ T cells activation [39–41].